Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ - PubMed (original) (raw)
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
Caitriona M Guinane et al. Therap Adv Gastroenterol. 2013 Jul.
Abstract
The human gut microbiota has become the subject of extensive research in recent years and our knowledge of the resident species and their potential functional capacity is rapidly growing. Our gut harbours a complex community of over 100 trillion microbial cells which influence human physiology, metabolism, nutrition and immune function while disruption to the gut microbiota has been linked with gastrointestinal conditions such as inflammatory bowel disease and obesity. Here, we review the many significant recent studies that have centred on further enhancing our understanding of the complexity of intestinal communities as well as their genetic and metabolic potential. These have provided important information with respect to what constitutes a 'healthy gut microbiota' while furthering our understanding of the role of gut microbes in intestinal diseases. We also highlight recently developed genomic and other tools that are used to study the gut microbiome and, finally, we consider the manipulation of the gut microbiota as a potential therapeutic option to treat chronic gastrointestinal disease.
Keywords: gastrointestinal disease; gut health; microbial diversity; microbial manipulation.
Conflict of interest statement
Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.
Figures
Figure 1.
The gut microbiota in health and intestinal disease. The gastrointestinal microbiota play a role in host physiology, metabolism and nutrition. An alteration in the gut microbial community is linked to a number of intestinal conditions, including cancer, obesity and a variety of bowel disorders. The contribution of beneficial components of the gut microbiome to host physiology, metabolism and immune function has become the focus of ever more attention, and will undoubtedly lead to new therapeutic approaches.
Similar articles
- Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC, Haziri D, Brzozowski T, Hess T, Heyman S, Kwiecien S, Konturek SJ, Koziel J. Konturek PC, et al. J Physiol Pharmacol. 2015 Aug;66(4):483-91. J Physiol Pharmacol. 2015. PMID: 26348073 Review. - Part 1: The Human Gut Microbiome in Health and Disease.
Bull MJ, Plummer NT. Bull MJ, et al. Integr Med (Encinitas). 2014 Dec;13(6):17-22. Integr Med (Encinitas). 2014. PMID: 26770121 Free PMC article. Review. - Beneficial modulation of the gut microbiota.
Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Walsh CJ, et al. FEBS Lett. 2014 Nov 17;588(22):4120-30. doi: 10.1016/j.febslet.2014.03.035. Epub 2014 Mar 26. FEBS Lett. 2014. PMID: 24681100 Review. - The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B. Stecher B. Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088 - [Gut microbiota: Description, role and pathophysiologic implications].
Landman C, Quévrain E. Landman C, et al. Rev Med Interne. 2016 Jun;37(6):418-23. doi: 10.1016/j.revmed.2015.12.012. Epub 2015 Dec 31. Rev Med Interne. 2016. PMID: 26749318 Review. French.
Cited by
- Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids.
Miller MA, Medina S. Miller MA, et al. Adv Funct Mater. 2024 Sep 18;34(38):2402514. doi: 10.1002/adfm.202402514. Epub 2024 Mar 13. Adv Funct Mater. 2024. PMID: 39309137 - Exploring the gut microbiota's crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles.
Li Y, Li J, Li S, Zhou S, Yang J, Xu K, Chen Y. Li Y, et al. Front Pharmacol. 2024 Jul 26;15:1437894. doi: 10.3389/fphar.2024.1437894. eCollection 2024. Front Pharmacol. 2024. PMID: 39130638 Free PMC article. Review. - The Gut-CNS Axis in Multiple Sclerosis.
Kadowaki A, Quintana FJ. Kadowaki A, et al. Trends Neurosci. 2020 Aug;43(8):622-634. doi: 10.1016/j.tins.2020.06.002. Epub 2020 Jul 7. Trends Neurosci. 2020. PMID: 32650957 Free PMC article. Review. - Smart Capsule for Targeted Detection of Inflammation Levels Inside the GI Tract.
Kadian S, Gopalakrishnan S, Selvamani V, Khan S, Meyer T, Thomas R, Rana MM, Irazoqui PP, Verma MS, Rahimi R. Kadian S, et al. IEEE Trans Biomed Eng. 2024 May;71(5):1565-1576. doi: 10.1109/TBME.2023.3343337. Epub 2024 Apr 22. IEEE Trans Biomed Eng. 2024. PMID: 38096093 - Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.
Hermanson JB, Tolba SA, Chrisler EA, Leone VA. Hermanson JB, et al. J Nutr Biochem. 2024 Nov;133:109704. doi: 10.1016/j.jnutbio.2024.109704. Epub 2024 Jul 17. J Nutr Biochem. 2024. PMID: 39029595 Review.
References
- Adlerberth I., Wold A. (2009) Establishment of the gut microbiota in Western infants. Acta Paediatr 98: 229–238 - PubMed
- Andreasen A., Larsen N., Pedersen-Skovsgaard T., Berg R., Moller K., Svendsen K., et al. (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104: 1831–1838 - PubMed
- Balkwill F., Mantovani A. (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539–545 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources